Analysis of cellular NO-GC expression in the murine heart and lineage determination in angiotensin II-induced fibrosis
NO-sensitive guanylyl cyclase (NO-GC) is involved in the (patho)physiology of the mammalian heart. However, little is known about the individual cardiac cell types that express NO-GC and the role of the enzyme in cardiac fibrosis. Here, we describe the cellular expression of NO-GC in healthy and fibrotic murine myocardium; these data were compared with scRNA-seq data. In healthy myocardium, NO-GC is strongly expressed in pericytes and smooth muscle cells but not in endothelial cells or cardiomyocytes. Angiotensin II induced cardiac hypertrophy and fibrosis; fibrotic lesions contained cells positive for NO-GC identified as activated fibroblasts. Lineage tracing indicates that NO-GC-expressing activated fibroblasts originate from PDGFRβ- and Tcf21-positive fibroblast precursors. Our data indicate NO-GC expression in cardiac pericytes and SMC in naive myocardium and in activated fibroblast in fibrotic heart tissue. NO-mediated signaling may modulate fibrotic responses underlying the action of NO-GC stimulators used in the therapy of heart failure.
Authors
- Alexander R. Pinto (ORCID: https://orcid.org/0000-0001-6421-4970)
- Andreas Friebe (ORCID: https://orcid.org/0000-0001-8178-3948)
- Malathi Dona
- Michelle D. Tallquist (ORCID: https://orcid.org/0000-0002-1383-144X)
- Annika Gaab
- Dieter Groneberg (ORCID: https://orcid.org/0000-0001-9673-433X)
- Lennart Kreutz
Institutions
- University of Hawaiʻi at Mānoa (US)
- Baker Heart and Diabetes Institute (AU)
- University of Würzburg (DE)
- Fraunhofer Institute for Silicate Research (DE)
Publication Details
- Journal
- iScience
- Published
- 2024-12-16
- DOI
- https://doi.org/10.1016/j.isci.2024.111615
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Heart Foundation of Australia
- Deutsche Forschungsgemeinschaft